ACTB and polycystic ovary syndrome: Through pathway enrichment analysis and hub gene miRNA networks, Heidarzadehpilehrood et al. highlighted ACTB, KRAS, JUNE, PTEN, and MAPK1 as potential therapeutic targets for PCOS treatment [52].